de Beaumais TA - Search Results

1

Body Surface Area-Based Dosing Regimen of Caspofungin in Children: a Population Pharmacokinetics Confirmatory Study.

Yang XM, Leroux S, Storme T, Zhang DL, de Beaumais TA, Shi HY, Yang YL, Wang XL, Zhao W, Jacqz-Aigrain E. Yang XM, et al. Among authors: de beaumais ta. Antimicrob Agents Chemother. 2019 Jun 24;63(7):e00248-19. doi: 10.1128/AAC.00248-19. Print 2019 Jul. Antimicrob Agents Chemother. 2019. PMID: 30988148 Free PMC article.

2

Intracellular disposition of methotrexate in acute lymphoblastic leukemia in children.

de Beaumais TA, Jacqz-Aigrain E. de Beaumais TA, et al. Curr Drug Metab. 2012 Jul;13(6):822-34. doi: 10.2174/138920012800840400. Curr Drug Metab. 2012. PMID: 22571483 Review.

3

Pharmacogenetics and individualized therapy in children: immunosuppressants, antidepressants, anticancer and anti-inflammatory drugs.

Elie V, de Beaumais T, Fakhoury M, Jacqz-Aigrain E. Elie V, et al. Pharmacogenomics. 2011 Jun;12(6):827-43. doi: 10.2217/pgs.11.19. Pharmacogenomics. 2011. PMID: 21692614 Review.

4

[Therapeutic drug monitoring of 6-thioguanine nucleotides in paediatric acute lymphoblastic leukaemia: interest and limits].

Fakhoury M, de Beaumais T, Médard Y, Jacqz-Aigrain E; Suivi Thérapeutique Pharmacologique de la Société Française de Pharmacologie et de Thérapeutique. Fakhoury M, et al. Therapie. 2010 May-Jun;65(3):187-93. doi: 10.2515/therapie/2010031. Epub 2010 Aug 11. Therapie. 2010. PMID: 20699069 Review. French.

5

mRNA expression of MDR1 and major metabolising enzymes in human fetal tissues.

Fakhoury M, de Beaumais T, Guimiot F, Azougagh S, Elie V, Medard Y, Delezoide AL, Jacqz-Aigrain E. Fakhoury M, et al. Drug Metab Pharmacokinet. 2009;24(6):529-36. doi: 10.2133/dmpk.24.529. Drug Metab Pharmacokinet. 2009. PMID: 20045988 Free article.

6

Suivi thérapeutique pharmacologique des 6-thioguanine nucléotides dans les leucémies aigues lymphoblastiques de l'enfant : intérêt et limites.

Fakhoury M, Jacqz-Aigrain E; pour le groupe Suivi Thérapeutique Pharmacologique de la Société Française de Pharmacologie et Thérapeutique; de Beaumais T, Médard Y. Fakhoury M, et al. Therapie. 2010 May-Jun;65(3):187-93. doi: 10.2515/therapie/2010031. Therapie. 2010. PMID: 27392985 French.

7

Characterization of a novel TPMT mutation associated with azathioprine-induced myelosuppression.

de Beaumais TA, Fakhoury M, Pigneur B, Viola S, Medard Y, Broly F, Jacqz-Aigrain E. de Beaumais TA, et al. Br J Clin Pharmacol. 2009 Nov;68(5):770-2. doi: 10.1111/j.1365-2125.2009.03439.x. Br J Clin Pharmacol. 2009. PMID: 19917002 Free PMC article. No abstract available.

8

Key factors associated with 6-thioguanine and 6-methylmercaptopurine nucleotide concentrations in children treated by thiopurine for acute leukaemia and inflammatory bowel disease.

de Beaumais TA, Lorrain S, Mamhoudi N, Simonin M, Martinez Vinson C, Medard Y, Petit A, Jacqz-Aigrain E. de Beaumais TA, et al. Br J Clin Pharmacol. 2024 Jan;90(1):209-219. doi: 10.1111/bcp.15894. Epub 2023 Sep 8. Br J Clin Pharmacol. 2024. PMID: 37621013 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

8 results

Search Page

Filters